nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A useful add-on international prognostic score for mastocytosis?
|
Barete, Stéphane |
|
|
6 |
12 |
p. e604-e605 |
artikel |
2 |
Blood products: unmet needs for essential medicines
|
Burnouf, Thierry |
|
|
6 |
12 |
p. e598-e599 |
artikel |
3 |
Essential medicines: a balancing act
|
The Lancet Haematology, |
|
|
6 |
12 |
p. e597 |
artikel |
4 |
Frontline therapy in multiple myeloma: fast start for a long game
|
Patriarca, Francesca |
|
|
6 |
12 |
p. e600-e601 |
artikel |
5 |
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
|
Sperr, Wolfgang R |
|
|
6 |
12 |
p. e638-e649 |
artikel |
6 |
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
|
Jackson, Graham H |
|
|
6 |
12 |
p. e616-e629 |
artikel |
7 |
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
|
Ahmed, Asra |
|
|
6 |
12 |
p. e630-e637 |
artikel |
8 |
Targeting the inflammatory cascade in haemophagocytic lymphohistiocytosis
|
Nikiforow, Sarah |
|
|
6 |
12 |
p. e602-e603 |
artikel |
9 |
The global need and availability of blood products: a modelling study
|
Roberts, Nicholas |
|
|
6 |
12 |
p. e606-e615 |
artikel |